The board of Chippenham-based pharmaceuticals business and inhaled drug development specialist Vectura has accepted the improved offer from Philip Morris International of 165p per share which has seen off the offer of 155p offered by Murano Bidco, a company indirectly controlled by funds managed by Carlyle Europe Partners V last week.

The proposed deal is continuing to attract controversy as Philip Morris, a company that produces cigarettes, notably the Marlboro brand, looks set control a company dedicated to alleviating the symptoms of smoking.

Date published: August 13, 2021

Subscriber content

To get unlimited access subscribe today


Already a subscriber? Login